You are here
Heparin and Lignocaine ampoules (Pfizer)
Recalls for product correction - potential for incorrect products in packages
Consumers and health professionals are advised that Pfizer, in consultation with the TGA, is undertaking recalls for product correction involving Heparin 5000 U/5 mL injection 50 pack (Batch A473, expiry date Feb 2019) and Lignocaine 50 mg/5 mL ampoules (Batch A313, expiry date Nov 2017) due to the potential for incorrect products in packages.
Details of both recalls can be found in the links below.